Breaking News
8 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Dr. Reddy's becomes the first company to receive Health Canada approval for generic semaglutide injection, ahead of all competing generics manufacturers.
Pharma Now Editorial Team

Regeneron's Phase 3 fianlimab-cemiplimab trial misses PFS significance vs. pembrolizumab, prompting manufacturing and pipeline reassessment.
Pharma Now Editorial Team

FDA flags multiple Amazon Basic Care levonorgestrel 1.5 mg lots delivered past expiration, raising distributor oversight and expiry control concerns.
Pharma Now Editorial Team

FDA issues a May 2026 approval letter for GSK's TWINRIX, continuing a documented post-approval supplement cycle for the combination hepatitis vaccine.
Pharma Now Editorial Team
